Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 485

1.

Safety and efficacy of glucose-insulin-potassium treatment in coronary artery bypass graft surgery and percutaneous coronary intervention.

Ali-Hassan-Sayegh S, Mirhosseini SJ, Zeriouh M, Dehghan AM, Shahidzadeh A, Karimi-Bondarabadi AA, Sabashnikov A, Popov AF.

Interact Cardiovasc Thorac Surg. 2015 Aug 11. pii: ivv222. [Epub ahead of print]

2.

Targeting reperfusion injury in the era of primary percutaneous coronary intervention: hope or hype?

Lønborg JT.

Heart. 2015 Jun 30. pii: heartjnl-2015-307804. doi: 10.1136/heartjnl-2015-307804. [Epub ahead of print] Review.

PMID:
26130664
3.

Combination therapy with remote ischaemic conditioning and insulin or exenatide enhances infarct size limitation in pigs.

Alburquerque-Béjar JJ, Barba I, Inserte J, Miró-Casas E, Ruiz-Meana M, Poncelas M, Vilardosa Ú, Valls-Lacalle L, Rodríguez-Sinovas A, Garcia-Dorado D.

Cardiovasc Res. 2015 Jul 15;107(2):246-54. doi: 10.1093/cvr/cvv171. Epub 2015 Jun 4.

PMID:
26045476
4.

Tetraparesis and failure of pacemaker capture induced by severe hyperkalemia: case report and systematic review of available literature.

Sanson G, Russo S, Iudicello A, Schiraldi F.

J Emerg Med. 2015 May;48(5):555-61.e3. doi: 10.1016/j.jemermed.2014.12.048. Epub 2015 Mar 9.

PMID:
25766426
5.

Stress hyperglycemia in acute myocardial infarction.

Koraćević G, Vasiljević S, Velicković-Radovanović R, Sakac D, Obradović S, Damjanović M, Krstić N, Zdravković M, Kostić T.

Vojnosanit Pregl. 2014 Sep;71(9):858-69. Review. No abstract available.

PMID:
25282785
6.

Diabetes: Glycaemia and insulin after acute myocardial infarction.

Dandona P, Chaudhuri A.

Nat Rev Endocrinol. 2014 Aug;10(8):448-50. doi: 10.1038/nrendo.2014.101. Epub 2014 Jul 1. No abstract available.

PMID:
24981456
7.

Refractory hypoglycemia and subsequent cardiogenic shock in starvation and refeeding: report of three cases.

Shimizu K, Ogura H, Wasa M, Hirose T, Shimazu T, Nagasaka H, Hirano K.

Nutrition. 2014 Sep;30(9):1090-2. doi: 10.1016/j.nut.2014.01.007. Epub 2014 Feb 15.

PMID:
24927630
8.

One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial).

Selker HP, Udelson JE, Massaro JM, Ruthazer R, D'Agostino RB, Griffith JL, Sheehan PR, Desvigne-Nickens P, Rosenberg Y, Tian X, Vickery EM, Atkins JM, Aufderheide TP, Sayah AJ, Pirrallo RG, Levy MK, Richards ME, Braude DA, Doyle DD, Frascone RJ, Kosiak DJ, Leaming JM, Van Gelder CM, Walter GP, Wayne MA, Woolard RH, Beshansky JR.

Am J Cardiol. 2014 May 15;113(10):1599-605. doi: 10.1016/j.amjcard.2014.02.010. Epub 2014 Mar 1.

9.

Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era.

Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ.

World J Cardiol. 2014 Mar 26;6(3):100-6. doi: 10.4330/wjc.v6.i3.100. Review.

10.

Reduced oxidative stress in STEMI patients treated by primary percutaneous coronary intervention and with antioxidant therapy: a systematic review.

Ekeløf S, Jensen SE, Rosenberg J, Gögenur I.

Cardiovasc Drugs Ther. 2014 Apr;28(2):173-81. doi: 10.1007/s10557-014-6511-3. Review.

PMID:
24532094
11.

The heart is better protected against myocardial infarction in the fed state compared to the fasted state.

Liepinsh E, Makrecka M, Kuka J, Makarova E, Vilskersts R, Cirule H, Sevostjanovs E, Grinberga S, Pugovics O, Dambrova M.

Metabolism. 2014 Jan;63(1):127-36. doi: 10.1016/j.metabol.2013.09.014. Epub 2013 Oct 18.

PMID:
24140100
12.

Current state of clinical translation of cardioprotective agents for acute myocardial infarction.

Kloner RA.

Circ Res. 2013 Aug 2;113(4):451-63. doi: 10.1161/CIRCRESAHA.112.300627. Review.

13.

Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt/mTOR and AMPK activation.

Mourouzis I, Giagourta I, Galanopoulos G, Mantzouratou P, Kostakou E, Kokkinos AD, Tentolouris N, Pantos C.

Metabolism. 2013 Oct;62(10):1387-93. doi: 10.1016/j.metabol.2013.05.008. Epub 2013 Jun 15.

PMID:
23773982
14.

Key advances in clinical cardiology.

Connolly M, Menown IB.

Adv Ther. 2013 Apr;30(4):369-86. doi: 10.1007/s12325-013-0024-5. Epub 2013 Apr 9. Review.

PMID:
23579862
15.

Hyperglycaemia in Acute Coronary Syndromes: Management of Hyperglycaemia in People with Acute Coronary Syndromes.

Centre for Clinical Practice at NICE (UK).

London: National Institute for Health and Clinical Excellence (UK); 2011 Oct.

16.
17.

Management of blood glucose in patients with acute coronary syndromes.

Lipska KJ, Kosiborod M.

Rev Cardiovasc Med. 2012;13(2-3):e77-88. Review.

PMID:
23160165
18.
19.

Management of hyperglycemia in a hospitalized patient with diabetes mellitus and cardiovascular disease.

Papak J, Kansagara D.

Am J Cardiol. 2012 Nov 6;110(9 Suppl):24B-31B. doi: 10.1016/j.amjcard.2012.08.034. Review.

PMID:
23062564
20.

[High-dose insulin therapy].

Shirakawa Y.

Chudoku Kenkyu. 2012 Sep;25(3):201-4. Review. Japanese. No abstract available.

PMID:
23057396
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk